Company Valuation: Rani Therapeutics Holdings, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 322.3 145.8 85.92 45.64 131.7 60.75 - -
Change - -54.75% -41.09% -46.89% 188.57% -53.87% - -
Enterprise Value (EV) 322.3 77.02 37.38 45.64 131.7 60.75 60.75 60.75
Change - -76.1% -51.46% 22.08% 188.57% -53.87% 0% 0%
P/E -38x -4.61x -2.5x -1.3x -3x -3.14x -2.77x -3.36x
PBR - 7.91x - - - - - -
PEG - -0x -0.64x 0.1x 0.1x 0.1x -0.2x 0.2x
Capitalization / Revenue 119x - - 44.4x 80.6x 9.52x 10.8x 4.37x
EV / Revenue 0x - - 0x 0x 9.52x 10.8x 4.37x
EV / EBITDA - - - - - - - -
EV / EBIT -0x -0x -0x -0x -0x -1.66x -1.41x -1.41x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -0.43 -1.28 -1.33 -1.05 -0.45 -0.1675 -0.19 -0.1567
Distribution rate - - - - - - - -
Net sales 1 2.717 - - 1.028 1.633 6.382 5.646 13.91
EBITDA -51.1 -62.9 -65.28 -52.29 - - - -
EBIT 1 -51.6 -63.45 -66.1 -49.6 -38.31 -36.6 -43.03 -42.97
Net income 1 -8.331 -30.59 -33.97 -30.02 -29.67 -30.68 -37.07 -34.81
Net Debt - -68.83 -48.54 - - - - -
Reference price 2 16.3500 5.9000 3.3200 1.3700 1.3500 0.5263 0.5263 0.5263
Nbr of stocks (in thousands) 19,712 24,720 25,880 33,312 97,551 115,425 - -
Announcement Date 3/31/22 3/22/23 3/20/24 3/31/25 3/26/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-3.14x - - - 60.75M
17.35x6.64x12.72x1.72% 66.33B
32.78x8.77x28.98x0.07% 60.62B
38.6x6.87x20.53x0.84% 55.5B
44.7x6.25x29.77x-.--% 47.58B
34.6x3.29x14.2x-.--% 43.69B
-20.57x54.42x-22.49x-.--% 37.27B
36.15x8.94x23.31x0.36% 36.57B
40.59x7.91x26.38x-.--% 32.22B
-73.93x14x-75.29x-.--% 26.58B
Average 14.71x 13.01x 6.46x 0.33% 41B
Weighted average by Cap. 21.69x 11.75x 11.42x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Rani Therapeutics Holdings, Inc.

Historical PBR trend

Valuation ratios - PBR - Rani Therapeutics Holdings, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Rani Therapeutics Holdings, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Rani Therapeutics Holdings, Inc.

  1. Stock Market
  2. Stocks
  3. RANI Stock
  4. Valuation Rani Therapeutics Holdings, Inc.